- Previous Close
3.0000 - Open
3.0000 - Bid 2.4500 x 40000
- Ask 2.7500 x 40000
- Day's Range
3.0000 - 3.0000 - 52 Week Range
2.3500 - 3.3100 - Volume
100 - Avg. Volume
338 - Market Cap (intraday)
1.746B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
20.00 - EPS (TTM)
0.1300 - Earnings Date Jan 30, 2025 - Feb 3, 2025
- Forward Dividend & Yield 0.11 (4.28%)
- Ex-Dividend Date Oct 29, 2024
- 1y Target Est
--
Parkway Life Real Estate Investment Trust (PLife REIT) is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 63 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.23 billion5 as at 31 December 2023. It owns the largest portfolio of strategically located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 59 assets of high-quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
www.plifereit.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PRKWF
View MorePerformance Overview: PRKWF
Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRKWF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRKWF
View MoreValuation Measures
Market Cap
1.76B
Enterprise Value
2.33B
Trailing P/E
20.24
Forward P/E
19.49
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.65
Price/Book (mrq)
1.61
Enterprise Value/Revenue
21.67
Enterprise Value/EBITDA
24.95
Financial Highlights
Profitability and Income Statement
Profit Margin
67.93%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
145.05M
Net Income Avi to Common (ttm)
98.54M
Diluted EPS (ttm)
0.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
57.07M
Total Debt/Equity (mrq)
57.37%
Levered Free Cash Flow (ttm)
--